Latest

Improving the accuracy and comfort of intravitreal injectionsAn intravitreal injection device can provide repeatable results and added comfort for the patient, removing the need for a drape and speculum.
Macular degeneration patients regain sight with stem cell implantsTwo patients with macular degeneration regained reading vision after receiving stem cells implanted with a new technique, according to researchers.
Early detection in AMD: An ounce of prevention is worth a pound of cureInterventions in AMD are most effective when administered early in the disease course. Studies provide evidence supporting this and a number of tools and techniques can be used to improve rates of early detection to improve patients’ long-term outcomes.
New retinal laser therapy options offer improvements to macular disease managementEndpoint management technology allows laser therapy to be applied within specific parameters to elicit a cellular response whilst avoiding tissue damage. The laser treatment can then be applied at high density, potentially leading to better therapeutic outcomes.
Moorfields research provides hope for choroideremia curePreliminary research has shown that ataluren is effective in overriding the nonsense mutation in choroideremia patients, however, further research is needed.
Intravitreal implant could bring significant cost savings to NHS EnglandA study has revealed that a budgetary saving per treated patient with the fluocinolone acetonide implant (Iluvien) versus ranibizumab (Lucentis) could lead to a significant cost-saving to NHS England.
Honors celebrate research, future generation in retinaSixteen fellows and residents show just why research in retina is on the cutting edge
Partner Perspective: Patient Case Study - CONTINUOUS MICRODOSING™ TREATMENT WITH ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19mg
Data demonstrate real-world benefits of fluocinolone acetonide implantReal-world data on a fluocinolone acetonide intravitreal implant show sustained benefits of switching to the treatment in pseudophakic eyes that are insufficiently responsive to other therapies.
Electroretinography: Out of the laboratory and into the clinicOCT has many benefits, yet falls short of reliably diagnosing and managing retinopathies and glaucoma. ERG remains the stalwart method for this application and this article highlights how technological advancements have enabled its introduction to the clinic.
var script= ' ';